50 results on '"Porte, Robert J."'
Search Results
2. Mechanisms of platelet-mediated liver regeneration.
- Author
-
Lisman, Ton and Porte, Robert J.
- Subjects
- *
BLOOD platelets , *LIVER regeneration , *VENOUS thrombosis , *HEMOSTASIS , *MITOGENS - Abstract
Platelets have multiple functions beyond their roles in thrombosis and hemostasis. Platelets support liver regeneration, which is required after partial hepatectomy and acute or chronic liver injury. Although it is widely assumed that platelets stimulate liver regeneration by local excretion of mitogens stored within platelet granules, definitive evidence for this is lacking, and alternative mechanisms deserve consideration. In-depth knowledge of mechanisms of plateletmediated liver regeneration may lead to new therapeutic strategies to treat patients with failing regenerative responses. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
3. Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis.
- Author
-
Mergental, Hynek and Porte, Robert J.
- Subjects
- *
LIVER transplantation , *LIVER cancer , *SURGICAL excision , *LYMPH nodes , *CANCER relapse , *HEPATITIS B - Abstract
Hepatocellular carcinoma (HCC) arising in noncirrhotic and nonfibrotic liver (NC-HCC) is a rare type of malignancy frequently found in healthy young individuals. Partial liver resection is the treatment of choice with expected 5-year survival rates between 40% and 70%. As a result of absence of any symptom, a considerable number of patients are diagnosed when the malignancy has progressed to an advanced stage and the tumor has turned already unresectable. Some other patients suffer from intrahepatic recurrence after previous liver resection that cannot be re-resected or locally ablated. In these situations, liver transplantation (LT) may be the only potentially curative treatment. The indication for LT in NC-HCC patients, however, is not well established. The preliminary results of recent analysis of the European Liver Transplant Registry (ELTR) together with a literature review identified over 150 patients transplanted for NC-HCC during the last 15 years. In contrast to the historical data, these studies showed 5-year survival rates at 50–70% in well-selected patients. Important determinants of poor outcome are macrovascular invasion, lymph node involvement, and time interval of <12 months when LT is used as rescue therapy for intrahepatic recurrence after a previous partial liver resection. Interestingly, outcomes after both liver resection and LT for NC-HCC are much less influenced by tumor size than is the case with cirrhotic HCC. A large tumor size per se should, therefore, not to be seen as a strict contraindication for performing LT in patients with NC-HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
4. Laparoscopic Versus Open Cholecystectomy: A Prospective Matched-Cohort Study.
- Author
-
PORTE, ROBERT J. and DE VRIES, BAS C.
- Published
- 1996
- Full Text
- View/download PDF
5. Hepatic artery thrombosis after liver transplantation: more than just a surgical complication?
- Author
-
Lisman, Ton and Porte, Robert J.
- Subjects
- *
BLOOD coagulation , *LIVER transplantation , *HEMORRHAGE , *THROMBOSIS ,EDITORIALS - Abstract
The article presents the author's comments on the thrombosis of the hepatic artery as one of the major complications after liver transplantation and its association with morbidity and graft loss. The author says although a patient with liver disease is generally considered to have a defective hemostatic system, evidences are increasing that bleeding tendency might not be reflected by these coagulation. He has also discussed a number of cases.
- Published
- 2009
- Full Text
- View/download PDF
6. Viability criteria assessment during liver machine perfusion.
- Author
-
Brüggenwirth, Isabel M. A., de Meijer, Vincent E., Porte, Robert J., and Martins, Paulo N.
- Published
- 2020
- Full Text
- View/download PDF
7. Long-term follow-up of a randomized trial of biliary drainage in perihilar cholangiocarcinoma.
- Author
-
Nooijen, Lynn E., Franssen, Stijn, Buis, Carlijn I., Dejong, Cornelis H.C., den Dulk, Marcel, van Delden, Otto M., Ijzermans, Jan N., Groot Koerkamp, Bas, Kazemier, Geert, van Lienden, Krijn, Klümpen, Heinz-Josef, Kuipers, Hendrien, Olij, Bram, Porte, Robert J., Rauws, Erik A., Voermans, Rogier P., van Gulik, Thomas M., Erdmann, Joris I., Roos, E., and Coelen, R.J.
- Subjects
- *
DRAINAGE , *CHOLANGIOCARCINOMA , *RANDOMIZED controlled trials - Abstract
The DRAINAGE trial was a randomized controlled trial comparing preoperative endoscopic (EBD) and percutaneous biliary drainage (PTBD) in patients with potentially resectable, perihilar cholangiocarcinoma (pCCA). The aim of this study was to compare the long-term outcomes. Patients were randomized in four tertiary referral centers. Follow-up data were available for all included patients. Primary outcome was overall survival (OS). Secondary outcomes were readmissions, and re-interventions not including in-trial interventions. A total of 54 patients were randomized; 27 in both groups. Median follow-up for both groups was 62 months (95% CI 54–70). The median OS was 13 months (95% CI 7.9–18.1) in the EBD and 7 months (95% CI 0.0–17.2) in the PTBD group (P = 0.28). Twenty (37%, n = 8 EBD vs n = 12 PTBD, P = 0.43) of 54 patients were readmitted at least once, mostly due to drainage-related complications (n = 13, 24%). Of note, 14 out of the 54 patients died within the trial. A total of 76 drainage procedures (32 EBD and 44 PTBD) were performed in 28 patients. The median number of stent or drain placements was 2 (2–4) for the EBD group and 2 (1–3) for the PTBD group (P = 0.77). Although this follow-up study represented a small cohort, no long-term differences in survival, readmissions, and drainage procedures for EBD and PTBD were found, even when comparing the resected and unresected group. However, this study demonstrates the complexity of biliary drainage for patients with potentially resectable pCCA, even in tertiary referral centers. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Emerging pan-resistance in Trichosporon species: a case report.
- Author
-
dos Santos, Claudy Oliveira, Zijlstra, Jan G., Porte, Robert J., Kampinga, Greetje A., van Diepeningen, Anne D., Sinha, Bhanu, Bathoorn, Erik, and Oliveira Dos Santos, Claudy
- Subjects
- *
TRICHOSPORON , *GASTROINTESTINAL system , *SKIN , *DERMATOMYCOSES , *OPPORTUNISTIC infections , *IMMUNOCOMPROMISED patients , *LIVER transplantation , *ANTIFUNGAL agents - Abstract
Background: Trichosporon species are ubiquitously spread and known to be part of the normal human flora of the skin and gastrointestinal tract. Trichosporon spp. normally cause superficial infections. However, in the past decade Trichosporon spp. are emerging as opportunistic agents of invasive fungal infections, particularly in severely immunocompromised patients. Clinical isolates are usually sensitive to triazoles, but strains resistant to multiple triazoles have been reported.Case Presentation: We report a high-level pan-azole resistant Trichosporon dermatis isolate causing an invasive cholangitis in a patient after liver re-transplantation. This infection occurred despite of fluconazole and low dose amphotericin B prophylaxis, and treatment with combined liposomal amphotericin B and voriconazole failed.Conclusion: This case and recent reports in literature show that not only bacteria are evolving towards pan-resistance, but also pathogenic yeasts. Prudent use of antifungals is important to withstand emerging antifungal resistance. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
9. Long-term normothermic machine preservation of human livers: what is needed to succeed?
- Author
-
Lascaris, Bianca, Thorne, Adam M., Lisman, Ton, Nijsten, Maarten W. N., Porte, Robert J., and de Meijer, Vincent E.
- Subjects
- *
MECHANICAL hearts , *OXYGEN carriers , *LIVER , *BILE salts , *WASTE products - Abstract
Although short-term machine perfusion (-24 h) allows for resuscitation and viability assessment of high-risk donor livers, the donor organ shortage might be further remedied by long-term perfusion machines. Extended preservation of injured donor livers may allow reconditioning, repairing, and regeneration. This review summarizes the necessary requirements and challenges for long-term liver machine preservation, which requires integrating multiple core physiological functions to mimic the physiological environment inside the body. A pump simulates the heart in the perfusion system, including automatically controlled adjustment of flow and pressure settings. Oxygenation and ventilation are required to account for the absence of the lungs combined with continuous blood gas analysis. To avoid pressure necrosis and achieve heterogenic tissue perfusion during preservation, diaphragm movement should be simulated. An artificial kidney is required to remove waste products and control the perfusion solution's composition. The perfusate requires an oxygen carrier, but will also be challenged by coagulation and activation of the immune system. The role of the pancreas can be mimicked through closed-loop control of glucose concentrations by automatic injection of insulin or glucagon. Nutrients and bile salts, generally transported from the intestine to the liver, have to be supplemented when preserving livers long term. Especially for long-term perfusion, the container should allow maintenance of sterility. In summary, the main challenge to develop a long-term perfusion machine is to maintain the liver's homeostasis in a sterile, carefully controlled environment. Long-term machine preservation of human livers may allow organ regeneration and repair, thereby ultimately solving the shortage of donor livers. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Development of a machine perfusion device for cold-to-warm machine perfusion.
- Author
-
van Leeuwen, Otto B., Brüggenwirth, Isabel M.A., Porte, Robert J., and Martins, Paulo N.
- Subjects
- *
PERFUSION - Published
- 2020
- Full Text
- View/download PDF
11. How to minimize blood loss during liver surgery in patients with cirrhosis.
- Author
-
Westerkamp, Andrie C., Lisman, Ton, and Porte, Robert J.
- Subjects
- *
LIVER diseases , *THROMBOPLASTIN , *BLOOD coagulation , *HEMOSTATICS , *BLOOD platelets , *HEMORRHAGE , *PATIENTS - Abstract
Patients with liver disease frequently have substantial changes in their haemostatic system. This is reflected in abnormal test results on routine coagulation screening assays such as the prothrombin time (PT), activated thromboplastin time (APTT) and platelet count. Traditionally, attempts were made to correct abnormalities in the haemostatic system as measured by routine coagulation assays prior to invasive procedures by infusion of platelets or fresh frozen plasma (FFP). Recent laboratory and clinical data have indicated that the haemostatic reserve in cirrhotic patients is relatively well maintained although the coagulation screening assays suggest otherwise. Pre-procedural correction of coagulation tests with blood products may therefore not be necessary, and may even have harmful side-effects. In particular, fluid overload resulting in exacerbation of portal hypertension by infusion of blood products may in fact promote bleeding. In recent years, it has become clear that reduction of the central and portal venous pressure by fluid restriction and avoidance of blood product transfusion is a beneficial strategy in minimizing bleeding during liver surgery in cirrhotic patients. Some investigators have even taken this a step further and suggested pre-procedural phlebotomy in liver transplant recipients. The aim of this review is to provide an overview of recent studies and developments which have changed our understanding of the clinical relevance of abnormal coagulation tests in patients with cirrhosis, and which have contributed to a reduction in blood loss and transfusion requirements when liver surgery is needed in these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
12. The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation.
- Author
-
Brüggenwirth, Isabel M. A., Werner, Maureen J. M., Adam, René, Polak, Wojciech G., Karam, Vincent, Heneghan, Michael A., Mehrabi, Arianeb, Klempnauer, Jürgen L., Paul, Andreas, Mirza, Darius F., Pratschke, Johann, Salizzoni, Mauro, Cherqui, Daniel, Allison, Michael, Soubrane, Olivier, Staffa, Steven J., Zurakowski, David, Porte, Robert J., and de Meijer, Vincent E.
- Subjects
- *
PROGNOSTIC models , *SURVIVAL analysis (Biometry) , *ADULTS , *SURVIVAL rate , *GRAFT survival - Abstract
Summary: High‐risk combinations of recipient and graft characteristics are poorly defined for liver retransplantation (reLT) in the current era. We aimed to develop a risk model for survival after reLT using data from the European Liver Transplantation Registry, followed by internal and external validation. From 2006 to 2016, 85 067 liver transplants were recorded, including 5581 reLTs (6.6%). The final model included seven predictors of graft survival: recipient age, model for end‐stage liver disease score, indication for reLT, recipient hospitalization, time between primary liver transplantation and reLT, donor age, and cold ischemia time. By assigning points to each variable in proportion to their hazard ratio, a simplified risk score was created ranging 0–10. Low‐risk (0–3), medium‐risk (4–5), and high‐risk (6–10) groups were identified with significantly different 5‐year survival rates ranging 56.9% (95% CI 52.8–60.7%), 46.3% (95% CI 41.1–51.4%), and 32.1% (95% CI 23.5–41.0%), respectively (P < 0.001). External validation showed that the expected survival rates were closely aligned with the observed mortality probabilities. The Retransplantation Risk Score identifies high‐risk combinations of recipient‐ and graft‐related factors prognostic for long‐term graft survival after reLT. This tool may serve as a guidance for clinical decision‐making on liver acceptance for reLT. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study.
- Author
-
Brüggenwirth, Isabel M.A., Reeven, Marjolein, Vasiliauskaitė, Indrė, Helm, Danny, Hoek, Bart, Schaapherder, Alexander F., Alwayn, Ian P.J., Berg, Aad P., Meijer, Vincent E., Darwish Murad, Sarwa, Polak, Wojciech G., and Porte, Robert J.
- Subjects
- *
LIVER transplantation , *DIABETES , *HEPATIC artery , *COHORT analysis , *REGRESSION analysis , *FETOFETAL transfusion - Abstract
Summary: With the growing incidence of diabetes mellitus (DM), an increasing number of organ donors with DM can be expected. We sought to investigate the association between donor DM with early post‐transplant outcomes. From a national cohort of adult liver transplant recipients (1996–2016), all recipients transplanted with a liver from a DM donor (n = 69) were matched 1:2 with recipients of livers from non‐DM donors (n = 138). The primary end‐point included early post‐transplant outcome, such as the incidence of primary nonfunction (PNF), hepatic artery thrombosis (HAT), and 90‐day graft survival. Cox regression analysis was used to analyze the impact of donor DM on graft failure. PNF was observed in 5.8% of grafts from DM donors versus 2.9% of non‐DM donor grafts (P = 0.31). Recipients of grafts derived from DM donors had a higher incidence of HAT (8.7% vs. 2.2%, P = 0.03) and decreased 90‐day graft survival (88.4% [70.9–91.1] vs. 96.4% [89.6–97.8], P = 0.03) compared to recipients of grafts from non‐DM donors. The adjusted hazard ratio for donor DM on graft survival was 2.21 (1.08–4.53, P = 0.03). In conclusion, donor DM is associated with diminished outcome early after liver transplantation. The increased incidence of HAT after transplantation of livers from DM donors requires further research. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. Hyperthermia-induced changes in liver physiology and metabolism: a rationale for hyperthermic machine perfusion.
- Author
-
Thorne, Adam M., Ubbink, Rinse, Brüggenwirth, Isabel M. A., Nijsten, Maarten W., Porte, Robert J., and de Meijer, Vincent E.
- Abstract
Liver transplantation is the standard treatment for end-stage liver disease. However, due to the ongoing disparity between supply and demand for optimal donor organs, there is increasing usage of extended criteria donor organs, including steatotic liver grafts. To mitigate the increased risks associated with extended criteria donor livers, ex situ oxygenated machine perfusion (MP) has received increasing attention in recent years as an emerging platform for dynamic preservation, reconditioning, and viability assessment to increase organ utilization. MP can be applied at different temperatures. During hypothermic MP (4 –12°C), liver metabolism is reduced, while oxygenation restores the intracellular levels of adenosine triphosphate. The liver is quickly “recharged” to support metabolism when at normothermia (35–37°C) and to ameliorate the detrimental effects of ischemia/reperfusion injury during transplantation. During normothermia, MP can be applied to assess hepatocellular and cholangiocellular viability. MP at hyperthermic (38°C) temperatures (HyMP), however, remains relatively understudied. The liver is an important component in the regulation of core body temperature and, as such, displays significant physiological and metabolic changes in response to different temperatures. Hyperthermia may promote vasodilation, increase aerobic metabolism and induce production of protective molecules such as heat shock proteins. Therefore, HyMP could provide an attractive reconditioning strategy for steatotic livers. In this review, we describe current literature on the physiological and metabolic effects of the liver at hyperthermia for human, rodents, and pigs and provide a rationale for using therapeutic HyMP during isolated liver machine perfusion to recondition extended criteria donor livers, including steatotic livers, before transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
15. Selected liver grafts from donation after circulatory death can be safely used for retransplantation – a multicenter retrospective study.
- Author
-
Reeven, Marjolein, Leeuwen, Otto B., Helm, Danny, Darwish Murad, Sarwa, Berg, Aad P., Hoek, Bart, Alwayn, Ian P.J., Polak, Wojciech G., and Porte, Robert J.
- Subjects
- *
PROPENSITY score matching , *LIVER , *LIVER transplantation , *RETROSPECTIVE studies , *KIDNEY exchange - Abstract
Summary: Due to the growing number of liver transplantations (LTs), there is an increasing number of patients requiring retransplantation (reLT). Data on the use of grafts from extended criteria donors (ECD), especially donation after circulatory death (DCD), for reLT are lacking. We aimed to assess the outcome of patients undergoing reLT using a DCD graft in the Netherlands between 2001 and July 2018. Propensity score matching was used to match each DCD‐reLT with three DBD‐reLT cases. Primary outcomes were patient and graft survival. Secondary outcome was the incidence of biliary complications, especially nonanastomotic strictures (NAS). 21 DCD‐reLT were compared with 63 matched DBD‐reLTs. Donors in the DCD‐reLT group had a significantly lower BMI (22.4 vs. 24.7 kg/m2, P‐value = 0.02). Comparison of recipient demographics and ischemia times yielded no significant differences. Patient and graft survival rates were comparable between the two groups. However, the occurrence of nonanastomotic strictures after DCD‐reLT was significantly higher (38.1% vs. 12.7%, P‐value = 0.02). ReLT with DCD grafts does not result in inferior patient and graft survival compared with DBD grafts in selected patients. Therefore, DCD liver grafts should not routinely be declined for patients awaiting reLT. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. Successful Thrombectomy via a Surgically Reopened Umbilical Vein for Extended Portal Vein Thrombosis Caused by Portal Vein Embolization prior to Extended Liver Resection.
- Author
-
Derksen, Wouter J.M., de Jong, Iris E.M., Buis, Carlijn I., Reyntjens, Koen M.E.M., Kater, G. Matthijs, Korteweg, Tijmen, Mazuri, Aryan, and Porte, Robert J.
- Subjects
- *
PORTAL vein , *UMBILICAL veins , *THROMBOSIS , *LIVER surgery , *PORTAL vein surgery , *LIVER , *THROMBOLYTIC therapy - Abstract
Selective portal vein embolization (PVE) before extended liver surgery is an accepted method to stimulate growth of the future liver remnant. Portal vein thrombosis (PVT) of the main stem and the non-targeted branches to the future liver remnant is a rare but major complication of PVE, requiring immediate revascularization. Without revascularization, curative liver surgery is not possible, resulting in a potentially life-threatening situation. We here present a new surgical technique to revascularize the portal vein after PVT by combining a surgical thrombectomy with catheter-based thrombolysis via the surgically reopened umbilical vein. This technique was successfully applied in a patient who developed thrombosis of the portal vein main stem, as well as the left portal vein and its branches to the left lateral segments after selective right-sided PVE in preparation for an extended right hemihepatectomy. The advantage of this technique is the avoidance of an exploration of hepatoduodenal ligament and a venotomy of the portal vein. The minimal surgical trauma facilitates additional intravascular thrombolytic therapy as well as the future right extended hemihepatectomy. We recommend this technique in patients with extensive PVT in which percutaneous less invasive therapies have been proven unsuccessful. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. Metabolic and lipidomic profiling of steatotic human livers during ex situ normothermic machine perfusion guides resuscitation strategies.
- Author
-
Raigani, Siavash, Karimian, Negin, Huang, Viola, Zhang, Anna M., Beijert, Irene, Geerts, Sharon, Nagpal, Sonal, Hafiz, Ehab O. A., Fontan, Fermin M., Aburawi, Mohamed M., Mahboub, Paria, Markmann, James F., Porte, Robert J., Uygun, Korkut, Yarmush, Martin, and Yeh, Heidi
- Subjects
- *
METABOLIC profile tests , *UNSATURATED fatty acids , *LIVER , *LIPID metabolism , *PERFUSION , *RESUSCITATION - Abstract
There continues to be a significant shortage of donor livers for transplantation. One impediment is the discard rate of fatty, or steatotic, livers because of their poor post-transplant function. Steatotic livers are prone to significant ischemia-reperfusion injury (IRI) and data regarding how best to improve the quality of steatotic livers is lacking. Herein, we use normothermic (37°C) machine perfusion in combination with metabolic and lipidomic profiling to elucidate deficiencies in metabolic pathways in steatotic livers, and to inform strategies for improving their function. During perfusion, energy cofactors increased in steatotic livers to a similar extent as non-steatotic livers, but there were significant deficits in anti-oxidant capacity, efficient energy utilization, and lipid metabolism. Steatotic livers appeared to oxidize fatty acids at a higher rate but favored ketone body production rather than energy regeneration via the tricyclic acid cycle. As a result, lactate clearance was slower and transaminase levels were higher in steatotic livers. Lipidomic profiling revealed ω-3 polyunsaturated fatty acids increased in non-steatotic livers to a greater extent than in steatotic livers. The novel use of metabolic and lipidomic profiling during ex situ normothermic machine perfusion has the potential to guide the resuscitation and rehabilitation of steatotic livers for transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list—a retrospective study.
- Author
-
Goet, Jorn C., Hansen, Bettina E., Tieleman, Madelon, van Hoek, Bart, van den Berg, Aad P., Polak, Wojciech G., Dubbeld, Jeroen, Porte, Robert J., Konijn‐Janssen, Cynthia, de Man, Robert A., Metselaar, Herold J., and de Vries, Annemarie C.
- Subjects
- *
CHOLANGITIS , *LIVER transplantation , *LIVER diseases , *MEDICAL care , *CIRRHOSIS of the liver - Abstract
Summary: Studies from the USA and Nordic countries indicate primary sclerosing cholangitis (PSC) patients have low mortality on the liver transplantation (LTx) waiting list. However, this may vary among geographical areas. Therefore, we compared waiting list mortality and post‐transplant survival between laboratory model for end‐stage liver disease (LM) and MELD exception (ME)‐prioritized PSC and non‐PSC candidates in a nationwide study in the Netherlands. A retrospective analysis of patients waitlisted from 2006 to 2013 was conducted. A total of 852 candidates (146 PSC) were waitlisted of whom 609 (71.5%) underwent LTx and 159 (18.7%) died before transplantation. None of the ME PSC patients died, and they had a higher probability of LTx than LM PSC [HR obtained by considering ME as a time‐dependent covariate (HRME 9.86; 95% CI 6.14–15.85)] and ME non‐PSC patients (HRME 4.60; 95% CI 3.78–5.61). After liver transplantation, PSC patients alive at 3 years of follow‐up had a higher probability of relisting than non‐PSC patients (HR 7.94; 95% CI 1.98–31.85) but a significantly lower mortality (HR 0.51; 95% CI 0.27–0.95). In conclusion, current LTx prioritization advantages PSC patients on the LTx waiting list. Receiving ME points is strongly associated with timely LTx. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
19. Repopulating the biliary tree from the peribiliary glands.
- Author
-
de Jong, Iris E.M., van Leeuwen, Otto B., Lisman, Ton, Gouw, Annette S.H., and Porte, Robert J.
- Subjects
- *
EPITHELIAL cells , *BILE duct diseases , *PATHOLOGICAL physiology , *CELL proliferation , *PROGENITOR cells - Abstract
The larger ducts of the biliary tree contain numerous tubulo-alveolar adnexal glands that are lined with biliary epithelial cells and connected to the bile duct lumen via small glandular canals. Although these peribiliary glands (PBG) were already described in the 19th century, their exact function and role in the pathophysiology and development of cholangiopathies have not become evident until recently. While secretion of serous and mucinous components into the bile was long considered as the main function of PBG, recent studies have identified PBG as an important source for biliary epithelial cell proliferation and renewal. Activation, dilatation, and proliferation of PBG (or the lack thereof) have been associated with various cholangiopathies. Moreover, PBG have been identified as niches of multipotent stem/progenitor cells with endodermal lineage traits. This has sparked research interest in the role of PBG in the pathogenesis of various cholangiopathies as well as bile duct malignancies. Deeper understanding of the regenerative capacity of the PBG may contribute to the development of novel regenerative therapeutics for previously untreatable hepatobiliary diseases. This article is part of a Special Issue entitled: Cholangiocytes in Health and Disease edited by Jesus Banales, Marco Marzioni, Nicholas LaRusso and Peter Jansen. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
20. Oxygenated hypothermic machine perfusion after static cold storage improves endothelial function of extended criteria donor livers.
- Author
-
Burlage, Laura C., Karimian, Negin, Westerkamp, Andrie C., Visser, Nienke, Matton, Alix P.m., Van Rijn, Rianne, Adelmeijer, Jelle, Wiersema-Buist, Janneke, Gouw, Annette S.h., Lisman, Ton, and Porte, Robert J.
- Subjects
- *
COLD storage , *KIDNEY transplantation , *LIVER transplantation , *ORGAN donors , *KRUPPEL-like factors , *HEALTH - Abstract
Background Lack of oxygen and biomechanical stimulation during static cold storage (SCS) of donor livers compromises endothelial cell function. We investigated the effect of end-ischemic oxygenated hypothermic machine perfusion (HMP) on endothelial cell function of extended criteria donor (ECD) livers. Methods Eighteen livers, declined for transplantation, were transported to our center using static cold storage (SCS). After SCS, 6 livers underwent two hours of HMP, and subsequent normothermic machine perfusion (NMP) to assess viability. Twelve control livers underwent NMP immediately after SCS. mRNA expression of transcription factor Krüppel-like-factor 2 (KLF2), endothelial nitric oxide synthase (eNOS), and thrombomodulin (TM) was quantified by RT-PCR. Endothelial cell function and injury were assessed by nitric oxide (NO) production and release of TM into the perfusate. Results In HMP livers, mRNA expression of KLF2 (p = 0.043), eNOS (p = 0.028), and TM (p = 0.028) increased significantly during NMP. In parallel, NO levels increased during NMP in HMP livers but not in controls. At the end of NMP cumulative TM release was significantly lower HMP livers, compared to controls (p = 0.028). Conclusion A short period of two hours oxygenated HMP restores endothelial cell viability after SCS and subsequent normothermic reoxygenation of ECD livers. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
21. Long-term results after transplantation of pediatric liver grafts from donation after circulatory death donors.
- Author
-
van Rijn, Rianne, Hoogland, Pieter E. R., Lehner, Frank, van Heurn, Ernest L. W., and Porte, Robert J.
- Subjects
- *
LIVER transplantation , *ORGAN donors , *BRAIN death in children , *SURGICAL complications , *GRAFT rejection - Abstract
Background: Liver grafts from donation after circulatory death (DCD) donors are increasingly accepted as an extension of the organ pool for transplantation. There is little data on the outcome of liver transplantation with DCD grafts from a pediatric donor. The objective of this study was to assess the outcome of liver transplantation with pediatric DCD grafts and to compare this with the outcome after transplantation of livers from pediatric donation after brain death (DBD) donors. Method: All transplantations performed with a liver from a pediatric donor (≤16 years) in the Netherlands between 2002 and 2015 were included. Patient survival, graft survival, and complication rates were compared between DCD and DBD liver transplantation. Results: In total, 74 liver transplantations with pediatric grafts were performed; twenty (27%) DCD and 54 (73%) DBD. The median donor warm ischemia time (DWIT) was 24 min (range 15–43 min). Patient survival rate at 10 years was 78% for recipients of DCD grafts and 89% for DBD grafts (p = 0.32). Graft survival rate at 10 years was 65% in recipients of DCD versus 76% in DBD grafts (p = 0.20). If donor livers in this study would have been rejected for transplantation when the DWIT ≥30 min (n = 4), the 10-year graft survival rate would have been 81% after DCD transplantation. The rate of non-anastomotic biliary strictures was 5% in DCD and 4% in DBD grafts (p = 1.00). Other complication rates were also similar between both groups. Conclusions: Transplantation of livers from pediatric DCD donors results in good long-term outcome especially when the DWIT is kept ≤30 min. Patient and graft survival rates are not significantly different between recipients of a pediatric DCD or DBD liver. Moreover, the incidence of non-anastomotic biliary strictures after transplantation of pediatric DCD livers is remarkably low. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. Does the meld system provide equal access to liver transplantation for patients with different ABO blood groups?
- Author
-
IJtsma, Alexander J.C., Hilst, Christian S., Nijkamp, Danielle M., Bottema, Jan T., Fidler, Vaclav, Porte, Robert J., and Slooff, Maarten J.H.
- Subjects
- *
LIVER transplantation , *ALLOCATION of organs, tissues, etc. , *BLOOD grouping & crossmatching , *ORGAN donors , *TRANSPLANTATION of organs, tissues, etc. , *PATIENTS - Abstract
This study investigates the relationship between blood group and waiting time until transplantation or death on the waiting list. All patients listed for liver transplantation in the Netherlands between 15 December 2006 and 31 December 2012, were included. Study variables were gender, age, year of listing, diagnosis, previous transplantations, blood group, urgency, and MELD score. Using a competing risks analysis, separate cumulative incidence curves were constructed for death on the waiting list and transplantation and used to evaluate outcomes.In 517 listings, the mean death rate per 100 patient-years was 10.4. A total of 375 (72.5% of all listings) were transplanted. Of all transplantations, 352 (93.9%) were ABO-identical and 23 (6.1%) ABO-compatible. The 5-year cumulative incidence of death was 11.2% ( SE 1.4%), and of transplantation 72.5% ( SE 2.0%). Patient blood group had no multivariate significant impact on the hazard of dying on the waiting list nor on transplantation. Age, MELD score, and urgency status were significantly related to the death on the waiting list and transplantation. More recent listing had higher probability of being transplanted. In the MELD era, patient blood group status does not have a significant impact on liver transplant waiting list mortality nor on waiting time for transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
23. Intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma is of limited value.
- Author
-
Mantel, Hendrik T.J., Westerkamp, Andrie C., Sieders, Egbert, Peeters, Paul M. J. G., Jong, Koert P., Boer, Marieke T., Kleine, Ruben H., Gouw, Annette S. H., and Porte, Robert J.
- Subjects
- *
FROZEN tissue sections , *CHOLANGIOCARCINOMA , *ONCOLOGIC surgery , *SURGICAL excision , *THERAPEUTICS ,BILE duct surgery - Abstract
Frozen section analysis ( FS) during cancer surgery is widely used to assess resection margins. However, in hilar cholangiocarcinoma ( HCCA), FS may be less reliable because of the specific growth characteristics of the tumor. The aim of this study was to determine the accuracy and consequences of intraoperative FS of the proximal bile duct margins in HCCA. Between 1990 and 2014, 67 patients underwent combined extrahepatic bile duct resection and partial liver resection for HCCA with the use of FS. Sensitivity and specificity of FS was 68% and 97%, respectively. Seventeen of 67 patients (25%) displayed a positive bile duct margin at FS. The false-negative rate was 16% (eight patients). Ten patients (15%) with a positive bile duct margin underwent an additional resection in an attempt to achieve negative margins, which succeeded in three patients (4%). However, only one of these three patients did not have concomitant lymph node metastases, which are associated with a poor prognosis by itself. The use of FS of the proximal bile duct is of limited clinical value because of the relatively low sensitivity, high risk of false-negative results, and the low rate of secondary obtained tumor-free resection margins. Supported by the literature, a new approach to the use of FS in HCCA should be adopted, reserving the technique only for cases in which a substantial additional resection is possible. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival.
- Author
-
Mantel, Hendrik T. J., Westerkamp, Andrie C., Adam, René, Bennet, William F., Seehofer, Daniel, Settmacher, Utz, Sánchez-Bueno, Francisco, Fabregat Prous, Joan, Boleslawski, Emmanuel, Friman, Styrbjörn, Porte, Robert J., and null, null
- Subjects
- *
CHOLANGIOCARCINOMA , *LIVER transplantation , *PATIENT selection , *ADJUVANT treatment of cancer , *CANCER chemotherapy , *CANCER radiotherapy , *THERAPEUTICS - Abstract
Liver transplantation for hilar cholangiocarcinoma (hCCA) has regained attention since the Mayo Clinic reported their favorable results with the use of a neo-adjuvant chemoradiation protocol. However, debate remains whether the success of the protocol should be attributed to the neo-adjuvant therapy or to the strict selection criteria that are being applied. The aim of this study was to investigate the value of patient selection alone on the outcome of liver transplantation for hCCA. In this retrospective study, patients that were transplanted for hCCA between1990 and 2010 in Europe were identified using the European Liver Transplant Registry (ELTR). Twenty-one centers reported 173 patients (69%) of a total of 249 patients in the ELTR. Twenty-six patients were wrongly coded, resulting in a study group of 147 patients. We identified 28 patients (19%) who met the strict selection criteria of the Mayo Clinic protocol, but had not undergone neo-adjuvant chemoradiation therapy. Five–year survival in this subgroup was 59%, which is comparable to patients with pretreatment pathological confirmed hCCA that were transplanted after completion of the chemoradiation protocol at the Mayo Clinic. In conclusion, although the results should be cautiously interpreted, this study suggests that with strict selection alone, improved survival after transplantation can be achieved, approaching the Mayo Clinic experience. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
25. Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients.
- Author
-
Stine, Jonathan G., Pelletier, Shawn J., Schmitt, Timothy M., Porte, Robert J., and Northup, Patrick G.
- Subjects
- *
HEPATIC artery , *THROMBOSIS , *COMPLICATIONS from organ transplantation , *SURGICAL complications , *LIVER transplantation , *DISEASES ,PORTAL vein diseases - Abstract
Background: Hepatic artery thrombosis is an uncommon but catastrophic complication following liver transplantation. We hypothesize that recipients with portal vein thrombosis are at increased risk. Methods: Data on all liver transplants in the U.S. during the MELD era through September 2014 were obtained from UNOS. Status one, multivisceral, living donor, re-transplants, pediatric recipients and donation after cardiac death were excluded. Logistic regression models were constructed for hepatic artery thrombosis with resultant graft loss within 90 days of transplantation. Results: 63,182 recipients underwent transplantation; 662 (1.1%) recipients had early hepatic artery thrombosis; of those, 91 (13.8%) had pre-transplant portal vein thrombosis, versus 7.5% with portal vein thrombosis but no hepatic artery thrombosis (p < 0.0001). Portal vein thrombosis was associated with an increased independent risk of hepatic artery thrombosis (OR 2.17, 95% CI 1.71-2.76, p < 0.001) as was donor risk index (OR 2.02, 95% CI 1.65-2.48, p < 0.001). Heparin use at cross clamp, INR, and male donors were all significantly associated with lower risk. Discussion: Pre-transplant portal vein thrombosis is associated with post-transplant hepatic artery thrombosis independent of other factors. Recipients with portal vein thrombosis might benefit from aggressive coagulation management and careful donor selection. More research is needed to determine causal mechanism. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
26. Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice.
- Author
-
Karimian, Golnar, Kirschbaum, Marc, Veldhuis, Zwanida J., Bomfati, Fernanda, Porte, Robert J., and Lisman, Ton
- Subjects
- *
FATTY liver , *VITAMIN E , *DISEASE progression , *HEPATECTOMY , *LABORATORY mice , *PATIENTS - Abstract
Background and Aim: The progression of non-alcoholic fatty liver disease (NAFLD) likely involves a ‘multiple hit’ mechanism. We hypothesized that partial hepatectomy, a procedure performed frequently in patients with NAFLD, would accelerate the progression of disease. Methods: C57BL/6JolaHsd mice were fed a choline-deficient L-amino acid-defined diet (CD-AA) or a choline-sufficient L-amino acid-defined control diet (CS-AA). Part of the mice in the CD-AA group received a diet enriched in vitamin E (~20 mg /day). Two weeks after the start of the diet, mice underwent a partial hepatectomy or a sham operation. Results: In the CD-AA group, NAFLD activity scores were significantly higher at 7 days after partial hepatectomy compared to the sham operated mice (3.7 ± 1.3 vs. 1.8 ± 0.7; P<0.05). In addition, TBARS, a measure for oxidative stress, in liver tissue of the CD-AA group were significantly higher at day 1, 3 and 7 after partial hepatectomy compared to the sham operated mice (P<0.05). Vitamin E therapy significantly reduced TBARS level at day 7 after partial hepatectomy compared to the CD-AA diet group (P< 0.05). Vitamin E suppletion reduced NAFLD activity score at day 7 after partial hepatectomy compared to the CD-AA group (2.3 ± 0.8 vs. 3.8 ± 1.0; P<0.05). Conclusion: Partial hepatectomy accelerates the progression of NAFLD. Disease progression induced by partial hepatectomy is substantially attenuated by vitamin E. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
27. Diffuse reflectance spectroscopy accurately quantifies various degrees of liver steatosis in murine models of fatty liver disease.
- Author
-
Westerkamp, Andrie C., Pully, Vishnu V., Karimian, Golnar, Bomfati, Fernanda, Veldhuis, Zwanida J., Wiersema-Buist, Janneke, Hendriks, Benno H. W., Lisman, Ton, and Porte, Robert J.
- Abstract
Background: A real-time objective evaluation for the extent of liver steatosis during liver transplantation is currently not available. Diffuse reflectance spectroscopy (DRS) rapidly and accurately assesses the extent of steatosis in human livers with mild steatosis. However, it is yet unknown whether DRS accurately quantifies moderate/severe steatosis and is able to distinguish between micro- and macrovesicular steatosis.Methods: C57BL/6JolaHsd mice were fed wit a choline-deficient L-amino acid-defined diet (CD-AA) or a choline-sufficient L-amino acid-defined control diet (CS-AA) for 3, 8, and 20 weeks. In addition B6.V-Lepob/OlaHsd (ob/ob) mice and their lean controls were studied. A total of 104 DRS measurements were performed in liver tissue ex vivo. The degree of steatosis was quantified from the DRS data and compared with histopathological analysis.Results: When assessed by histology, livers of mice fed with a CD-AA and CS-AA diet displayed macrovesicular steatosis (range 0-74 %), ob/ob mice revealed only microvesicular steatosis (range 75-80 %), and their lean controls showed no steatosis. The quantification of steatosis by DRS correlated well with pathology (correlation of 0.76 in CD-AA/CS-AA fed mice and a correlation of 0.75 in ob/ob mice). DRS spectra did not distinguish between micro- and macrovesicular steatosis. In samples from CD-AA/CS-AA fed mice, the DRS was able to distinguish between mild and moderate/severe steatosis with a sensitivity and specificity of 86 and 81 %, respectively.Conclusion: DRS can quantify steatosis with good agreement to histopathological analysis. DRS may be useful for real-time objective evaluation of liver steatosis during liver transplantation, especially to differentiate between mild and moderate/severe steatosis. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
28. Horizontal RNA transfer mediates platelet-induced hepatocyte proliferation.
- Author
-
Kirschbaum, Marc, Karimian, Golnar, Adelmeijer, Jelle, Giepmans, Ben N. G., Porte, Robert J., and Usman, Ton
- Subjects
- *
LIVER degeneration , *BLOOD platelets , *RNA , *CELL lines , *CELL proliferation - Abstract
Liver regeneration is stimulated by blood platelets, but the molecular mechanisms involved are largely unexplored. Although platelets are anucleate, they do contain coding or regulatory RNAs that can be functional within the platelet or, after transfer, in other cell types. Here, we show that platelets and platelet-like particles (PLPs) derived from the megakaryoblastic cell line MEG-01 stimulate proliferation of HepG2 cells. Platelets or PLPs were internalized within 1 hour by HepG2 cells and accumulated in the perinuclear region of the hepatocyte. Platelet internalization also occurred following a partial hepatectomy in mice. Annexin A5 blocked platelet internalization and HepG2 proliferation. We labeled total RNA of MEG-01 cells by incorporation of 5-ethynyluridine (EU) and added EU-labeled PLPs to HepG2 cells. PLP-derived RNA was detected in the cytoplasm of the HepG2 cell. We next generated PLPs containing green fluorescent protein (GFP)-tagged actin messenger RNA. PLPs did not synthesize GFP, but in coculture with HepG2 cells, significant GFP protein synthesis was demonstrated. RNA-degrading enzymes partly blocked the stimulating effect of platelets on hepatocyte proliferation. Thus, platelets stimulate hepatocyte proliferation via a mechanism that is dependent on platelet internalization by hepatocytes followed by functional transfer of RNA stored in the anucleate platelet. This mechanism may contribute to platelet-mediated liver regeneration. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
29. High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death.
- Author
-
Dulk, A. Claire, Sebib Korkmaz, Kerem, Rooij, Bert-Jan F., Sutton, Michael E., Braat, Andries E., Inderson, Akin, Dubbeld, Jeroen, Verspaget, Hein W., Porte, Robert J., and Hoek, Bart
- Subjects
- *
AMINOTRANSFERASES , *LIVER transplantation , *ORGAN donation , *CUMULATIVE distribution function , *MULTIVARIATE analysis - Abstract
Orthotopic liver transplantation ( OLT) with donation after circulatory death ( DCD) often leads to a higher first week peak alanine aminotransferase ( ALT) and a higher rate of biliary nonanastomotic strictures ( NAS) as compared to donation after brain death ( DBD). This retrospective study was to evaluate whether an association exists between peak ALT and the development of NAS in OLT with livers from DBD ( n = 399) or DCD ( n = 97) from two transplantation centers. Optimal cutoff value of peak ALT for risk of development of NAS post- DCD- OLT was 1300 IU/l. The 4-year cumulative incidence of NAS after DCD- OLT was 49.5% in patients with a high ALT peak post- OLT, compared with 11.3% in patients with a low ALT peak. ( P < 0.001). No relation between peak ALT and NAS was observed after DBD- OLT. Multivariate analysis revealed peak ALT ≥1300 IU/l [adjusted hazard ratio ( aHR) = 3.71, confidence interval ( CI) (1.26-10.91)] and donor age [ aHR = 1.04, CI 1.00-1.07] to be independently associated with development of NAS post- DCD- OLT. A peak ALT of <1300 IU/l carries a risk for NAS similar to DBD- OLT. Thus, in DCD- OLT, but not in DBD- OLT, peak ALT discriminates patients at high or low risk for NAS. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
30. Diffuse reflectance spectroscopy: toward real-time quantification of steatosis in liver.
- Author
-
Evers, Daniel J., Westerkamp, Andrie C., Spliethoff, Jarich W., Pully, Vishnu V., Hompes, Daphne, Hendriks, Benno H. W., Prevoo, Warner, Velthuysen, Marie-Louise F., Porte, Robert J., and Ruers, Theo J. M.
- Subjects
- *
REFLECTANCE spectroscopy , *PREDICATE calculus , *FATTY degeneration , *HISTOPATHOLOGY , *STATISTICAL correlation - Abstract
Assessment of fatty liver grafts during orthotopic liver transplantation is a challenge due to the lack of real-time analysis options during surgery. Diffuse reflectance spectroscopy ( DRS) could be a new diagnostic tool to quickly assess steatosis. Eight hundred and seventy-eight optical measurements were performed in vivo in 17 patients in liver tissue during surgery and ex vivo on liver resection specimens from 41 patients. Liver steatosis was quantified from the collected optical spectra and compared with the histology analysis from the measurement location by three independent pathologists. Twenty two patients were diagnosed with <5% steatosis, 15 patients had mild steatosis, and four had moderate steatosis. Severe steatosis was not identified. Intraclass correlation between the pathologists analysis was 0.949. A correlation of 0.854 was found between the histology and DRS analyses of liver steatosis ex vivo. For the same liver tissue, a correlation of 0.925 was demonstrated between in vivo and ex vivo DRS analysis for steatosis quantification. DRS can quantify steatosis in liver tissue both in vivo and ex vivo with good agreement compared to histopathology analysis. This analysis can be performed real time and may therefore be useful for fast objective assessment of liver steatosis in liver surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
31. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
- Author
-
Westerkamp, Andrie C., de Boer, Marieke T., van den Berg, Aad P., Gouw, Annette S. H., and Porte, Robert J.
- Subjects
- *
ISCHEMIA , *LIVER transplantation , *BLOOD circulation disorders , *TRANSPLANTATION of organs, tissues, etc. , *ORGAN donors - Abstract
Background: Livers with moderate (30-60%) macrovesicular steatosis have been associated with poor outcome after transplantation. Aim of this study was to examine the outcome after transplantation of livers with moderate macrovesicular steatosis when the cold ischemia time (CIT) is kept very short. Methods: Postoperative outcome of 19 recipients of a moderate steatotic liver were compared with a matched control group of 95 recipients of a nonsteatotic liver graft (1:5 ratio). We studied graft/patient survival rates, incidences of primary nonfunction, postoperative complications (classified according to the Clavien- Dindo classification), first-week postoperative hepatic injury serum markers (AST/ALT), and liver function tests (PT time/bilirubin/lactate). In addition, we studied reversal of graft steatosis in follow-up biopsies. Results: Median CIT in livers with moderate steatosis and in controls was below 8 h in both groups. Although short- and long-term patient/graft survival rates and results of liver function tests were similar, serum markers of hepatic injury and postoperative complications (especially grade IVa) were significantly higher in recipients of a moderate steatotic liver. Reversal of steatosis was seen in 9 of the 11 (82%) recipients with follow-up liver biopsies. Conclusion: Despite the association with severe postoperative complications, moderate macrovesicular steatotic livers can be used successfully for transplantation if the CIT is kept very short. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
32. Preoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial.
- Author
-
Wiggers, Jimme K., Coelen, Robert J.S., Rauws, Erik A.J., van Delden, Otto M., van Eijck, Casper H.J., de Jonge, Jeroen, Porte, Robert J., Buis, Carlijn I., Dejong, Cornelis H.C., Molenaar, I. Quintus, Besselink, Marc G.H., Busch, Olivier R.C., Dijkgraaf, Marcel G.W., and van Gulik, Thomas M.
- Subjects
- *
LIVER surgery , *PERCUTANEOUS transhepatic cholangiography , *CHOLANGIOCARCINOMA , *SURGICAL complications , *COMPARATIVE studies , *RANDOMIZED controlled trials , *THERAPEUTICS - Abstract
Background: Liver surgery in perihilar cholangiocarcinoma (PHC) is associated with high postoperative morbidity because the tumor typically causes biliary obstruction. Preoperative biliary drainage is used to create a safer environment prior to liver surgery, but biliary drainage may be harmful when severe drainage-related complications deteriorate the patients' condition or increase the risk of postoperative morbidity. Biliary drainage can cause cholangitis/cholecystitis, pancreatitis, hemorrhage, portal vein thrombosis, bowel wall perforation, or dehydration. Two methods of preoperative biliary drainage are mostly applied: endoscopic biliary drainage, which is currently used in most regional centers before referring patients for surgical treatment, and percutaneous transhepatic biliary drainage. Both methods are associated with severe drainage-related complications, but two small retrospective series found a lower incidence in the number of preoperative complications after percutaneous drainage compared to endoscopic drainage (18-25% versus 38-60%, respectively). The present study randomizes patients with potentially resectable PHC and biliary obstruction between preoperative endoscopic or percutaneous transhepatic biliary drainage. Methods/Design: The study is a multi-center trial with an "all-comers" design, randomizing patients between endoscopic or percutaneous transhepatic biliary drainage. All patients selected to potentially undergo a major liver resection for presumed PHC are eligible for inclusion in the study provided that the biliary system in the future liver remnant is obstructed (even if they underwent previous inadequate endoscopic drainage). Primary outcome measure is the total number of severe preoperative complications between randomization and exploratory laparotomy. The study is designed to detect superiority of percutaneous drainage: a provisional sample size of 106 patients is required to detect a relative decrease of 50% in the number of severe preoperative complications (alpha = 0.95; beta = 0.8). Interim analysis after inclusion of 53 patients (50%) will provide the definitive sample size. Secondary outcome measures encompass the success of biliary drainage, quality of life, and postoperative morbidity and mortality. Discussion: The DRAINAGE trial is designed to identify a difference in the number of severe drainage-related complications after endoscopic and percutaneous transhepatic biliary drainage in patients selected to undergo a major liver resection for perihilar cholangiocarcinoma. Trial registration: Netherlands Trial Register [NTR4243, 11 October 2013]. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
33. Criteria for Viability Assessment of Discarded Human Donor Livers during Ex Vivo Normothermic Machine Perfusion.
- Author
-
Sutton, Michael E., op den Dries, Sanna, Karimian, Negin, Weeder, Pepijn D., de Boer, Marieke T., Wiersema-Buist, Janneke, Gouw, Annette S. H., Leuvenink, Henri G. D., Lisman, Ton, and Porte, Robert J.
- Subjects
- *
ORGAN donors , *LIVER transplantation , *GRAFT rejection , *BIOMARKERS , *PERFUSION , *LIVER cells - Abstract
Although normothermic machine perfusion of donor livers may allow assessment of graft viability prior to transplantation, there are currently no data on what would be a good parameter of graft viability. To determine whether bile production is a suitable biomarker that can be used to discriminate viable from non-viable livers we have studied functional performance as well as biochemical and histological evidence of hepatobiliary injury during ex vivo normothermic machine perfusion of human donor livers. After a median duration of cold storage of 6.5 h, twelve extended criteria human donor livers that were declined for transplantation were ex vivo perfused for 6 h at 37°C with an oxygenated solution based on red blood cells and plasma, using pressure controlled pulsatile perfusion of the hepatic artery and continuous portal perfusion. During perfusion, two patterns of bile flow were identified: (1) steadily increasing bile production, resulting in a cumulative output of ≥30 g after 6 h (high bile output group), and (2) a cumulative bile production <20 g in 6 h (low bile output group). Concentrations of transaminases and potassium in the perfusion fluid were significantly higher in the low bile output group, compared to the high bile output group. Biliary concentrations of bilirubin and bicarbonate were respectively 4 times and 2 times higher in the high bile output group. Livers in the low bile output group displayed more signs of hepatic necrosis and venous congestion, compared to the high bile output group. In conclusion, bile production could be an easily assessable biomarker of hepatic viability during ex vivo machine perfusion of human donor livers. It could potentially be used to identify extended criteria livers that are suitable for transplantation. These ex vivo findings need to be confirmed in a transplant experiment or a clinical trial. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
34. Hypothermic Oxygenated Machine Perfusion Prevents Arteriolonecrosis of the Peribiliary Plexus in Pig Livers Donated after Circulatory Death.
- Author
-
op den Dries, Sanna, Sutton, Michael E., Karimian, Negin, de Boer, Marieke T., Wiersema-Buist, Janneke, Gouw, Annette S. H., Leuvenink, Henri G. D., Lisman, Ton, and Porte, Robert J.
- Subjects
- *
OXYGENATORS , *PERFUSION , *NECROSIS , *LIVER transplantation , *COLD therapy , *ORGAN donors , *ISCHEMIA , *PREVENTION - Abstract
Background: Livers derived from donation after circulatory death (DCD) are increasingly accepted for transplantation. However, DCD livers suffer additional donor warm ischemia, leading to biliary injury and more biliary complications after transplantation. It is unknown whether oxygenated machine perfusion results in better preservation of biliary epithelium and the peribiliary vasculature. We compared oxygenated hypothermic machine perfusion (HMP) with static cold storage (SCS) in a porcine DCD model. Methods: After 30 min of cardiac arrest, livers were perfused in situ with HTK solution (4°C) and preserved for 4 h by either SCS (n = 9) or oxygenated HMP (10°C; n = 9), using pressure-controlled arterial and portal venous perfusion. To simulate transplantation, livers were reperfused ex vivo at 37°C with oxygenated autologous blood. Bile duct injury and function were determined by biochemical and molecular markers, and a systematic histological scoring system. Results: After reperfusion, arterial flow was higher in the HMP group, compared to SCS (251±28 vs 166±28 mL/min, respectively, after 1 hour of reperfusion; p = 0.003). Release of hepatocellular enzymes was significantly higher in the SCS group. Markers of biliary epithelial injury (biliary LDH, gamma-GT) and function (biliary pH and bicarbonate, and biliary transporter expression) were similar in the two groups. However, histology of bile ducts revealed significantly less arteriolonecrosis of the peribiliary vascular plexus in HMP preserved livers (>50% arteriolonecrosis was observed in 7 bile ducts of the SCS preserved livers versus only 1 bile duct of the HMP preserved livers; p = 0.024). Conclusions: Oxygenated HMP prevents arteriolonecrosis of the peribiliary vascular plexus of the bile ducts of DCD pig livers and results in higher arterial flow after reperfusion. Together this may contribute to better perfusion of the bile ducts, providing a potential advantage in the post-ischemic recovery of bile ducts. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
35. Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis.
- Author
-
Potze, Wilma, Arshad, Freeha, Adelmeijer, Jelle, Blokzijl, Hans, van den Berg, Arie P., Meijers, Joost C. M., Porte, Robert J., and Lisman, Ton
- Subjects
- *
TREATMENT of cirrhosis of the liver , *ANTITHROMBINS , *ANTICOAGULANTS , *BLOOD plasma , *THROMBOSIS complications , *THROMBOSIS , *CARDIOVASCULAR disease treatment - Abstract
Background: Treatment and prevention of thrombotic complications is frequently required in patients with cirrhosis. However anticoagulant therapy is often withheld from these patients, because of the perceived bleeding diathesis. As a result of the limited clinical experience, the anticoagulant of choice for the various indications is still not known. Objectives: We evaluated the in vitro effect of clinically approved anticoagulant drugs in plasma from patients with cirrhosis. Patients/Methods: Thirty patients with cirrhosis and thirty healthy controls were studied. Thrombin generation assays were performed before and after addition of unfractionated heparin, low molecular weight heparin, fondaparinux, dabigatran, and rivaroxaban, to estimate anticoagulant potencies of these drugs. Results: Addition of dabigatran led to a much more pronounced reduction in endogenous thrombin potential in patients compared to controls (72.6% reduction in patients vs. 12.8% reduction in controls, P<0.0001). The enhanced effect of dabigatran was proportional to the severity of disease. In contrast, only a slightly increased anticoagulant response to heparin and low molecular weight heparin and even a reduced response to fondaparinux and rivaroxaban was observed in plasma from cirrhotic patients as compared to control plasma. Conclusions: The anticoagulant potency of clinically approved drugs differs substantially between patients with cirrhosis and healthy individuals. Whereas dabigatran and, to a lesser extent, heparin and low molecular weight heparin are more potent in plasma from patients with cirrhosis, fondaparinux and rivaroxaban showed a decreased anticoagulant effect. These results may imply that in addition to dose adjustments based on altered pharmacokinetics, drug-specific dose adjustments based on altered anticoagulant potency may be required in patients with cirrhosis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
36. The price of donation after cardiac death in liver transplantation: a prospective cost-effectiveness study.
- Author
-
Hilst, Christian S., IJtsma, Alexander J.C., Bottema, Jan T., Hoek, Bart, Dubbeld, Jeroen, Metselaar, Herold J., Kazemier, Geert, den Berg, Aad P., Porte, Robert J., and Slooff, Maarten J.H.
- Subjects
- *
LIVER transplantation , *ORGAN donors , *BRAIN death , *COST effectiveness , *SURGICAL complications , *ORGAN donation - Abstract
This study aims to perform a detailed prospective observational multicenter cost-effectiveness study by comparing liver transplantations with Donation after Brain Death ( DBD) and Donation after Cardiac Death ( DCD) grafts. All liver transplantations in the three Dutch liver transplant centers between 2004 and 2009 were included with 1-year follow-up. Primary outcome parameter was cost per life year after transplantation. Secondary outcome parameters were 1-year patient and graft survival, complications, and patient-level costs. From 382 recipients that underwent 423 liver transplantations, 293 were primarily transplanted with DBD and 89 with DCD organs. Baseline characteristics were not different between both groups. The Donor Risk Index was significantly different as were cold and warm ischemic time. Ward stay was significantly longer in DCD transplantations. Patient and graft survival were not significantly different. Patients receiving DCD organs had more and more severe complications. The cost per life year for DBD was € 88 913 compared to € 112 376 for DCD. This difference was statistically significant. DCD livers have more and more severe complications, more reinterventions and consequently higher costs than DBD livers. However, patient and graft survival was not different in this study. Reimbursement should be differentiated to better accommodate DCD transplantations. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
37. Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study.
- Author
-
van Keimpema, Loes, Nevens, Frederik, Adam, René, Porte, Robert J., Fikatas, Panagiotis, Becker, Thomas, Kirkegaard, Preben, Metselaar, Herold J., and Drenth, Joost P. H.
- Subjects
- *
ABDOMEN , *LIVER transplantation , *LIVER diseases , *TRANSPLANTATION of organs, tissues, etc. , *ABDOMINAL pain - Abstract
Summary Patients with end-stage isolated polycystic liver disease (PCLD) suffer from incapacitating symptoms because of very large liver volumes. Liver transplantation (LT) is the only curative option. This study assesses the feasibility of LT in PCLD. We used the European Liver Transplant Registry (ELTR) database to extract demographics and outcomes of 58 PCLD patients. We used Kaplan-Meier survival analysis for survival rates. Severe abdominal pain (75%) was the most prominent symptom, while portal hypertension (35%) was the most common complication in PCLD. The explantation of the polycystic liver was extremely difficult in 38% of patients, because of presence of adhesions from prior therapy (17%). Karnofsky score following LT was 90%. The 1- and 5-year graft survival rate was 94.3% and 87.5%, while patient survival rate was 94.8% and 92.3%, respectively. Survival rates after LT for PCLD are good. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
38. Intra-operative continuous renal replacement therapy during combined liver–kidney transplantation in two patients with primary hyperoxaluria type 1.
- Author
-
Franssen, Casper F. M., Kema, Ido P., Eleveld, Douglas J., Porte, Robert J., and Van der Heide, Jaap J. Homan
- Subjects
- *
KIDNEY transplantation , *OXALATES , *HOMOGRAFTS , *HEMODIALYSIS , *KIDNEY abnormalities - Abstract
Liver–kidney transplantation in patients with primary hyperoxaluria type 1 (PH1) and a high systemic oxalate load is often complicated by oxalate deposition in the renal allograft and loss of renal function. Intensive pre- and post-operative haemodialysis (HD) cannot completely prevent rises in plasma oxalate levels during transplantation because of rebound from saturated oxalate stores. Continuous renal replacement therapy may overcome this problem. In two PH1 patients with extensive oxalate accumulation, we found that intra-operative continuous venovenous haemodiafiltration effectively cleared oxalate and kept oxalate at relatively low levels following preoperative HD. [ABSTRACT FROM PUBLISHER]
- Published
- 2011
- Full Text
- View/download PDF
39. Analysis of differences in outcome of two European liver transplant centers.
- Author
-
Nemes, Balázs, Polak, Wojtek, Ther, Gábor, Hendriks, Herman, Kóbori, Lászl, Porte, Robert J., Sárváry, Enikõ, de Jong, Koert P., Doros, Attila, Gerlei, Zsuzsa, van den Berg, Aad P, Fehérvári, Imre, Görög, Dénes, Peeters, Paul M., Járay, Jenõ, and Slooff, Maarten J. H
- Subjects
- *
LIVER transplantation , *ACADEMIC medical centers , *UNIVERSITY hospitals ,SEMMELWEIS University (Budapest, Hungary) - Abstract
Authors analyzed the differences in the outcome of two European liver transplant centers differing in case volume and experience. The first was the Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary (SEB) and the second the University Medical Center Groningen, Groningen, The Netherlands (UMCG). We investigated if such differences could be explained. The 1-, 3- and 5-year patient survival in the UMCG was 86%, 80%, and 77% compared with 65%, 56%, and 55% in SEB. Graft survival at the same time points was 79%, 71%, and 66% in the UMCG and 62%, 55%, and 53% in SEB. Significant differences were present regarding the donor and recipient age, diagnosis mix, disease severity and operation variables, per-operative transfusion rate, vascular complications, postoperative infection rate, and need for renal replacement. To determine factors correlating with survival, a separate uni- and multivariate analysis was performed in each center individually, between study parameters and patient survival. In both centers, peri-operative red blood cell (RBC) transfusion rate was a significant predictor for patient survival. The difference in blood loss can be explained by different operation techniques and shorter operation time in SEB, with consequently less time spent on hemostasis. It was jointly concluded that measures to reduce blood loss by adapting the operation technique might lead to improved survival and reduced morbidity. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
40. THE EFFECTS OF LONG-TERM GRAFT PRESERVATION ON INTRAOPERATIVE HEMOSTATIC CHANGES IN LIVER TRANSPLANTATION.
- Author
-
BAKKER, C. MINKE, BLANKENSTEIJN, JAN D., SCHLEJEN, PETER, PORTE, ROBERT J., GOMES, MARIA J., LAMPE, HARALD I. H., STIBBE, JEANNE, and TERPSTRA, ONNO T.
- Published
- 1994
- Full Text
- View/download PDF
41. Ex situ normothermic machine perfusion of donor livers using a haemoglobin‐based oxygen carrier: a viable alternative to red blood cells.
- Author
-
Vries, Yvonne, Leeuwen, Otto B., Matton, Alix P. M., Fujiyoshi, Masato, Meijer, Vincent E., and Porte, Robert J.
- Subjects
- *
PERFUSION , *ORGAN donors , *LIVER transplantation - Published
- 2018
- Full Text
- View/download PDF
42. Oxygen Transport during Ex Situ Machine Perfusion of Donor Livers Using Red Blood Cells or Artificial Oxygen Carriers.
- Author
-
Bodewes, Silke B., van Leeuwen, Otto B., Thorne, Adam M., Lascaris, Bianca, Ubbink, Rinse, Lisman, Ton, Monbaliu, Diethard, De Meijer, Vincent E., Nijsten, Maarten W. N., and Porte, Robert J.
- Subjects
- *
OXYGEN carriers , *ERYTHROCYTES , *BLOOD substitutes , *ARTIFICIAL cells , *PERFUSION , *OXYGEN - Abstract
Oxygenated ex situ machine perfusion of donor livers is an alternative for static cold preservation that can be performed at temperatures from 0 °C to 37 °C. Organ metabolism depends on oxygen to produce adenosine triphosphate and temperatures below 37 °C reduce the metabolic rate and oxygen requirements. The transport and delivery of oxygen in machine perfusion are key determinants in preserving organ viability and cellular function. Oxygen delivery is more challenging than carbon dioxide removal, and oxygenation of the perfusion fluid is temperature dependent. The maximal oxygen content of water-based solutions is inversely related to the temperature, while cellular oxygen demand correlates positively with temperature. Machine perfusion above 20 °C will therefore require an oxygen carrier to enable sufficient oxygen delivery to the liver. Human red blood cells are the most physiological oxygen carriers. Alternative artificial oxygen transporters are hemoglobin-based oxygen carriers, perfluorocarbons, and an extracellular oxygen carrier derived from a marine invertebrate. We describe the principles of oxygen transport, delivery, and consumption in machine perfusion for donor livers using different oxygen carrier-based perfusion solutions and we discuss the properties, advantages, and disadvantages of these carriers and their use. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
43. Transmission of idiopathic thrombocytopenic purpura during orthotopic liver transplantation.
- Author
-
Pereboom, Ilona T. A., de Boer, Marieke T., Haagsma, Elizabeth B., van der Heide, Frans, Porcelijn, Leendert, Lisman, Ton, and Porte, Robert J.
- Subjects
- *
CASE studies , *PEOPLE with diabetes , *CROHN'S disease , *LIVER transplantation , *THROMBOCYTOPENIA , *ORGAN donors , *ARTERIOSCLEROSIS , *PURPURA (Pathology) , *PATIENTS - Abstract
The article presents a case study of a 44-year-old man with diabetes mellitus type I and Crohn's disease who underwent re-transplantation of the liver for ischemic-type biliary lesions and cholangitis. The patient underwent his first liver transplantation for primary sclerosing cholangitis in 2002. He has no history of thrombocytopenia. The patient's donor has arteriosclerosis and before he died, he was positive of purpura and acute thrombocytopenia.
- Published
- 2010
- Full Text
- View/download PDF
44. Tryptophan Metabolism via the Kynurenine Pathway: Implications for Graft Optimization during Machine Perfusion.
- Author
-
Zhang, Anna, Carroll, Cailah, Raigani, Siavash, Karimian, Negin, Huang, Viola, Nagpal, Sonal, Beijert, Irene, Porte, Robert J., Yarmush, Martin, Uygun, Korkut, and Yeh, Heidi
- Subjects
- *
AMINO acid derivatives , *TRYPTOPHAN , *KYNURENINE , *AMINO acid metabolism , *PERFUSION - Abstract
Access to liver transplantation continues to be hindered by the severe organ shortage. Extended-criteria donor livers could be used to expand the donor pool but are prone to ischemia-reperfusion injury (IRI) and post-transplant graft dysfunction. Ex situ machine perfusion may be used as a platform to rehabilitate discarded or extended-criteria livers prior to transplantation, though there is a lack of data guiding the utilization of different perfusion modalities and therapeutics. Since amino acid derivatives involved in inflammatory and antioxidant pathways are critical in IRI, we analyzed differences in amino acid metabolism in seven discarded non-steatotic human livers during normothermic- (NMP) and subnormothermic-machine perfusion (SNMP) using data from untargeted metabolomic profiling. We found notable differences in tryptophan, histamine, and glutathione metabolism. Greater tryptophan metabolism via the kynurenine pathway during NMP was indicated by significantly higher kynurenine and kynurenate tissue concentrations compared to pre-perfusion levels. Livers undergoing SNMP demonstrated impaired glutathione synthesis indicated by depletion of reduced and oxidized glutathione tissue concentrations. Notably, ATP and energy charge ratios were greater in livers during SNMP compared to NMP. Given these findings, several targeted therapeutic interventions are proposed to mitigate IRI during liver machine perfusion and optimize marginal liver grafts during SNMP and NMP. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
45. Split-Liver Ex Situ Machine Perfusion: A Novel Technique for Studying Organ Preservation and Therapeutic Interventions.
- Author
-
Huang, Viola, Karimian, Negin, Detelich, Danielle, Raigani, Siavash, Geerts, Sharon, Beijert, Irene, Fontan, Fermin M., Aburawi, Mohamed M., Ozer, Sinan, Banik, Peony, Lin, Florence, Karabacak, Murat, Hafiz, Ehab O.A., Porte, Robert J., Uygun, Korkut, Markmann, James F., and Yeh, Heidi
- Subjects
- *
VASCULAR resistance , *PERFUSION , *HUMAN experimentation - Abstract
Ex situ machine perfusion is a promising technology to help improve organ viability prior to transplantation. However, preclinical studies using discarded human livers to evaluate therapeutic interventions and optimize perfusion conditions are limited by significant graft heterogeneity. In order to improve the efficacy and reproducibility of future studies, a split-liver perfusion model was developed to allow simultaneous perfusion of left and right lobes, allowing one lobe to serve as a control for the other. Eleven discarded livers were surgically split, and both lobes perfused simultaneously on separate perfusion devices for 3 h at subnormothermic temperatures. Lobar perfusion parameters were also compared with whole livers undergoing perfusion. Similar to whole-liver perfusions, each lobe in the split-liver model exhibited a progressive decrease in arterial resistance and lactate levels throughout perfusion, which were not significantly different between right and left lobes. Split liver lobes also demonstrated comparable energy charge ratios. Ex situ split-liver perfusion is a novel experimental model that allows each graft to act as its own control. This model is particularly well suited for preclinical studies by avoiding the need for large numbers of enrolled livers necessary due to the heterogenous nature of discarded human liver research. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
46. Renal temperature reduction progressively favors mitochondrial ROS production over respiration in hypothermic kidney preservation.
- Author
-
Hendriks, Koen D. W., Brüggenwirth, Isabel M. A., Maassen, Hanno, Gerding, Albert, Bakker, Barbara, Porte, Robert J., Henning, Robert H., and Leuvenink, Henri G. D.
- Subjects
- *
KIDNEYS , *RESPIRATION , *LOW temperatures , *REACTIVE oxygen species , *TEMPERATURE , *PERFUSION , *OXYGEN consumption , *KIDNEY physiology , *ANIMAL experimentation , *ANTIOXIDANTS , *COMPARATIVE studies , *EPITHELIAL cells , *HYDROGEN peroxide , *INDUCED hypothermia , *RESEARCH methodology , *MEDICAL cooperation , *MITOCHONDRIA , *PRESERVATION of organs, tissues, etc. , *RESEARCH , *SWINE , *EVALUATION research - Abstract
Background: Hypothermia, leading to mitochondrial inhibition, is widely used to reduce ischemic injury during kidney preservation. However, the exact effect of hypothermic kidney preservation on mitochondrial function remains unclear.Methods: We evaluated mitochondrial function [i.e. oxygen consumption and production of reactive oxygen species (ROS)] in different models (porcine kidney perfusion, isolated kidney mitochondria, and HEK293 cells) at temperatures ranging 7-37 °C.Results: Lowering temperature in perfused kidneys and isolated mitochondria resulted in a rapid decrease in oxygen consumption (65% at 27 °C versus 20% at 7 °C compared to normothermic). Decreased oxygen consumption at lower temperatures was accompanied by a reduction in mitochondrial ROS production, albeit markedly less pronounced and amounting only 50% of normothermic values at 7 °C. Consequently, malondialdehyde (a marker of ROS-induced lipid peroxidation) accumulated in cold stored kidneys. Similarly, low temperature incubation of kidney cells increased lipid peroxidation, which is due to a loss of ROS scavenging in the cold.Conclusions: Lowering of temperature highly affects mitochondrial function, resulting in a progressive discrepancy between the lowering of mitochondrial respiration and their production of ROS, explaining the deleterious effects of hypothermia in transplantation procedures. These results highlight the necessity to develop novel strategies to decrease the formation of ROS during hypothermic organ preservation. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
47. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DCD trial.
- Author
-
van Rijn, Rianne, van den Berg, Aad P., Erdmann, Joris I., Heaton, Nigel, van Hoek, Bart, de Jonge, Jeroen, Leuvenink, Henri G. D., Mahesh, Shekar V. K., Mertens, Sarah, Monbaliu, Diethard, Muiesan, Paolo, Perera, M. Thamara P. R., Polak, Wojciech G., Rogiers, Xavier, Troisi, Roberto I., de Vries, Yvonne, and Porte, Robert J.
- Subjects
- *
CHOLANGITIS , *RANDOMIZED controlled trials , *LIVER transplantation , *COLD storage - Abstract
Background: The major concern in liver transplantation of grafts from donation after circulatory death (DCD) donors remains the high incidence of non-anastomotic biliary strictures (NAS). Machine perfusion has been proposed as an alternative strategy for organ preservation which reduces ischemia-reperfusion injury (IRI). Experimental studies have shown that dual hypothermic oxygenated machine perfusion (DHOPE) is associated with less IRI, improved hepatocellular function, and better preserved mitochondrial and endothelial function compared to conventional static cold storage (SCS). Moreover, DHOPE was safely applied with promising results in a recently performed phase-1 study. The aim of the current study is to determine the efficacy of DHOPE in reducing the incidence of NAS after DCD liver transplantation.Methods: This is an international multicenter randomized controlled trial. Adult patients (≥18 yrs. old) undergoing transplantation of a DCD donor liver (Maastricht category III) will be randomized between the intervention and control group. In the intervention group, livers will be subjected to two hours of end-ischemic DHOPE after SCS and before implantation. In the control group, livers will be subjected to care as usual with conventional SCS only. Primary outcome is the incidence of symptomatic NAS diagnosed by a blinded adjudication committee. In all patients, magnetic resonance cholangiography will be obtained at six months after transplantation.Discussion: DHOPE is associated with reduced IRI of the bile ducts. Whether reduced IRI of the bile ducts leads to lower incidence of NAS after DCD liver transplantation can only be examined in a randomized controlled trial.Trial Registration: The trial was registered in Clinicaltrials.gov in September 2015 with the identifier NCT02584283 . [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
48. Metabolic profiling during ex vivo machine perfusion of the human liver.
- Author
-
Bruinsma, Bote G., Sridharan, Gautham V., Weeder, Pepijn D., Avruch, James H., Saeidi, Nima, Özer, Sinan, Geerts, Sharon, Porte, Robert J., Heger, Michal, van Gulik, Thomas M., Martins, Paulo N., Markmann, James F., Yeh, Heidi, and Uygun, Korkut
- Published
- 2016
- Full Text
- View/download PDF
49. Preoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial.
- Author
-
Wiggers, Jimme K, Coelen, Robert Js, Rauws, Erik Aj, van Delden, Otto M, van Eijck, Casper Hj, de Jonge, Jeroen, Porte, Robert J, Buis, Carlijn I, Dejong, Cornelis Hc, Molenaar, I Quintus, Besselink, Marc Gh, Busch, Olivier Rc, Dijkgraaf, Marcel Gw, van Gulik, Thomas M, Coelen, Robert J S, Rauws, Erik A J, van Eijck, Casper H J, Dejong, Cornelis H C, Besselink, Marc G H, and Busch, Olivier R C
- Abstract
Background: Liver surgery in perihilar cholangiocarcinoma (PHC) is associated with high postoperative morbidity because the tumor typically causes biliary obstruction. Preoperative biliary drainage is used to create a safer environment prior to liver surgery, but biliary drainage may be harmful when severe drainage-related complications deteriorate the patients' condition or increase the risk of postoperative morbidity. Biliary drainage can cause cholangitis/cholecystitis, pancreatitis, hemorrhage, portal vein thrombosis, bowel wall perforation, or dehydration. Two methods of preoperative biliary drainage are mostly applied: endoscopic biliary drainage, which is currently used in most regional centers before referring patients for surgical treatment, and percutaneous transhepatic biliary drainage. Both methods are associated with severe drainage-related complications, but two small retrospective series found a lower incidence in the number of preoperative complications after percutaneous drainage compared to endoscopic drainage (18-25% versus 38-60%, respectively). The present study randomizes patients with potentially resectable PHC and biliary obstruction between preoperative endoscopic or percutaneous transhepatic biliary drainage.Methods/design: The study is a multi-center trial with an "all-comers" design, randomizing patients between endoscopic or percutaneous transhepatic biliary drainage. All patients selected to potentially undergo a major liver resection for presumed PHC are eligible for inclusion in the study provided that the biliary system in the future liver remnant is obstructed (even if they underwent previous inadequate endoscopic drainage). Primary outcome measure is the total number of severe preoperative complications between randomization and exploratory laparotomy. The study is designed to detect superiority of percutaneous drainage: a provisional sample size of 106 patients is required to detect a relative decrease of 50% in the number of severe preoperative complications (alpha = 0.95; beta = 0.8). Interim analysis after inclusion of 53 patients (50%) will provide the definitive sample size. Secondary outcome measures encompass the success of biliary drainage, quality of life, and postoperative morbidity and mortality.Discussion: The DRAINAGE trial is designed to identify a difference in the number of severe drainage-related complications after endoscopic and percutaneous transhepatic biliary drainage in patients selected to undergo a major liver resection for perihilar cholangiocarcinoma.Trial Registration: Netherlands Trial Register [ NTR4243 , 11 October 2013]. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
50. Recipient’s Genetic R702W NOD2 Variant Is Associated with an Increased Risk of Bacterial Infections after Orthotopic Liver Transplantation.
- Author
-
Janse, Marcel, de Rooij, Bert-Jan F., van Hoek, Bart, van den Berg, Arie P., Porte, Robert J., Blokzijl, Hans, Coenraad, Minneke J., Hepkema, Bouke G., Schaapherder, Alexander F., Ringers, Jan, Weersma, Rinse K., and Verspaget, Hein W.
- Subjects
- *
GENETIC polymorphisms , *BACTERIAL diseases , *LIVER transplantation , *LIVER surgery , *SURGICAL complications , *POSTOPERATIVE period , *INTERNAL medicine - Abstract
Introduction:Orthotopic liver transplantation (OLT) is accompanied by a significant postoperative infection risk. Immunosuppression to prevent rejection increases the susceptibility to infections, mainly by impairing the adaptive immune system. Genetic polymorphisms in the lectin complement pathway of the donor have recently been identified as important risk determinants of clinically significant bacterial infection (CSI) after OLT. Another genetic factor involved in innate immunity is NOD2, which was reported to be associated with increased risk of spontaneous bacterial peritonitis in cirrhotic patients. Methods:We assessed association of three genetic NOD2 variants (R702W, G908R and 3020insC) with increased risk of CSI after OLT. 288 OLT recipient-donor pairs from two tertiary referral centers were genotyped for the three NOD2 variants. The probability of CSI in relation to NOD2 gene variants was determined with cumulative incidence curves and log-rank analysis. Results:The R702W NOD2 variant in the recipient was associated with CSI after OLT. Eight out of 15 (53.3%) individuals with a mutated genotype compared to 80/273 (29.3%) with wild type genotype developed CSI (p=0.027, univariate cox regression), illustrated by a higher frequency of CSI after OLT over time (p=0.0003, log rank analysis). Multivariate analysis (including the donor lectin complement pathway profile) showed independence of this R702W NOD2 association from other risk factors (HR 2.0; p=0.04). The other NOD2 variants, G908R and 3020insC, in the recipient were not associated with CSI. There was no association with CSI after OLT for any of the NOD2 variants in the donor. Conclusion:The mutated NOD2 R702W genotype in the recipient is independently associated with an increased risk of bacterial infections after liver transplantation, indicating a predisposing role for this genetic factor impairing the recipient’s innate immune system. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.